연구동향 분석
박사

유전자발현 프로파일링을 통한 피부 기저세포암의 분자학적 분류 : Molecular Classification of Basal Cell Carcinoma of Skin by Gene Expression Profiling

임효섭 2015년

논문상세정보
인용/피인용
' 유전자발현 프로파일링을 통한 피부 기저세포암의 분자학적 분류 : Molecular Classification of Basal Cell Carcinoma of Skin by Gene Expression Profiling' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • basal cell carcinoma
  • gene expression profiling
  • heterogeneity
  • non-melanoma skin cancer
  • squamous cell carcinoma
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
201 0

0.0%

' 유전자발현 프로파일링을 통한 피부 기저세포암의 분자학적 분류 : Molecular Classification of Basal Cell Carcinoma of Skin by Gene Expression Profiling' 의 참고문헌

  • Yamazaki F, Aragane Y, Kawada A, Tezuka T: Immunohistochemical detection fornuclear beta-catenin in sporadic basal cell carcinoma. Br J Dermatol 145: 771-777,2001
  • Woo HG, Lee JH, Yoon JH, Kim CY, Lee HS, Jang JJ, Yi NJ, Suh KS, Lee KU,Park ES, Thorgeirsson SS, Kim YJ: Identification of a cholangiocarcinoma-like geneexpression trait in hepatocellular carcinoma. Cancer Res 70: 3034-3041, 2010
  • Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M,Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, WrightG, Bader GD, Morris Q: The GeneMANIA prediction server: biological networkintegration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214-220, 201037
  • Vieira SA, Deininger MW, Sorour A, Sinclair P, Foroni L, Goldman JM, Melo JV:Transcription factor BACH2 is transcriptionally regulated by the BCR/ABLoncogene. Genes Chromosomes Cancer 32: 353-363, 2001
  • Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ,Benz C, Eppenberger U, Eppenberger-Castori S: Increased expression of urokinasetypeplasminogen activator mRNA determines adverse prognosis in ErbB2-positiveprimary breast cancer. J Clin Oncol 24: 4245-4253, 2006
  • Ulrich C, Kanitakis J, Stockfleth E, Euvrard S: Skin cancer in organ transplantrecipients--where do we stand today? Am J Transplant 8: 2192-2198, 2008
  • Suzuki R, Shimodaira H: Pvclust: an R package for assessing the uncertainty inhierarchical clustering. Bioinformatics 22: 1540-1542, 2006
  • Skelly MM, Troy A, Duffy MJ, Mulcahy HE, Duggan C, Connell TG, O'DonoghueDP, Sheahan K: Urokinase-type plasminogen activator in colorectal cancer:relationship with clinicopathological features and patient outcome. Clin Cancer Res3: 1837-1840, 1997
  • Serewko MM, Popa C, Dahler AL, Smith L, Strutton GM, Coman W, Dicker AJ,Saunders NA: Alterations in gene expression and activity during squamous cellcarcinoma development. Cancer Res 62: 3759-3765, 200236
  • Santos CR, Schulze A: Lipid metabolism in cancer. Febs j 279: 2610-2623, 2012
  • Santibanez JF: Transforming growth factor-Beta and urokinase-type plasminogenactivator: dangerous partners in tumorigenesis-implications in skin cancer. ISRNDermatol 2013: 597927, 2013
  • Rubin AI, Chen EH, Ratner D: Basal-cell carcinoma. N Engl J Med 353: 2262-2269,2005
  • Romer J, Pyke C, Lund LR, Ralfkiaer E, Dano K: Cancer cell expression ofurokinase-type plasminogen activator receptor mRNA in squamous cell carcinomasof the skin. J Invest Dermatol 116: 353-358, 2001
  • Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB,Coldiron BM: Incidence estimate of nonmelanoma skin cancer in the United States,2006. Arch Dermatol 146: 283-287, 2010
  • Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, MetgeB, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J: The geneexpression profiles of primary and metastatic melanoma yields a transition point oftumor progression and metastasis. BMC Med Genomics 1: 13, 2008
  • Quintana RM, Dupuy AJ, Bravo A, Casanova ML, Alameda JP, Page A, Sanchez-Viera M, Ramirez A, Navarro M: A transposon-based analysis of gene mutationsrelated to skin cancer development. J Invest Dermatol 133: 239-248, 2013
  • Nindl I, Dang C, Forschner T, Kuban RJ, Meyer T, Sterry W, Stockfleth E:Identification of differentially expressed genes in cutaneous squamous cellcarcinoma by microarray expression profiling. Mol Cancer 5: 30, 200635
  • Lind MH, Rozell B, Wallin RP, van Hogerlinden M, Ljunggren HG, Toftgard R, SurI: Tumor necrosis factor receptor 1-mediated signaling is required for skin cancerdevelopment induced by NF-kappaB inhibition. Proc Natl Acad Sci U S A 101:4972-4977, 2004
  • Liang Y, Wu H, Lei R, Chong RA, Wei Y, Lu X, Tagkopoulos I, Kung SY, Yang Q,Hu G, Kang Y: Transcriptional network analysis identifies BACH1 as a masterregulator of breast cancer bone metastasis. J Biol Chem 287: 33533-33544, 2012
  • Leiter U, Garbe C: Epidemiology of melanoma and nonmelanoma skin cancer--therole of sunlight. Adv Exp Med Biol 624: 89-103, 2008
  • Lee CH, Olson P, Evans RM: Minireview: lipid metabolism, metabolic diseases, andperoxisome proliferator-activated receptors. Endocrinology 144: 2201-2207, 2003
  • Kwon SM, Cho H, Choi JH, Jee BA, Jo Y, Woo HG: Perspectives of integrativecancer genomics in next generation sequencing era. Genomics Inform 10: 69-73,2012
  • Kim GK, Del Rosso JQ, Bellew S: Skin cancer in asians: part 1: nonmelanoma skincancer. J Clin Aesthet Dermatol 2: 39-42, 2009
  • Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA:Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580,2004
  • Heller ER, Gor A, Wang D, Hu Q, Lucchese A, Kanduc D, Katdare M, Liu S, SinhaAA: Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: agenomic approach. Int J Oncol 42: 583-596, 201334
  • Harbeck N, Kates RE, Gauger K, Willems A, Kiechle M, Magdolen V, Schmitt M:Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumorderivedfactors with a high prognostic and predictive impact in breast cancer.Thromb Haemost 91: 450-456, 2004
  • Haider AS, Peters SB, Kaporis H, Cardinale I, Fei J, Ott J, Blumenberg M, BowcockAM, Krueger JG, Carucci JA: Genomic analysis defines a cancer-specific geneexpression signature for human squamous cell carcinoma and distinguishesmalignant hyperproliferation from benign hyperplasia. J Invest Dermatol 126: 869-881, 2006
  • Fajas L: Re-thinking cell cycle regulators: the cross-talk with metabolism. FrontOncol 3: 4, 2013
  • Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display ofgenome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868, 1998
  • Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA:DAVID: Database for Annotation, Visualization, and Integrated Discovery. GenomeBiol 4: P3, 2003
  • Crowson AN: Basal cell carcinoma: biology, morphology and clinical implications.Mod Pathol 19 Suppl 2: S127-147, 2006
  • Coussens LM, Werb Z: Inflammation and cancer. Nature 420: 860-867, 200233
  • Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A:STAT proteins: from normal control of cellular events to tumorigenesis. J CellPhysiol 197: 157-168, 2003
  • Bowman T, Garcia R, Turkson J, Jove R: STATs in oncogenesis. Oncogene 19:2474-2488, 2000
  • Backvall H, Asplund A, Gustafsson A, Sivertsson A, Lundeberg J, Ponten F:Genetic tumor archeology: microdissection and genetic heterogeneity in squamousand basal cell carcinoma. Mutat Res 571: 65-79, 2005
  • Asplund A, Gry Bjorklund M, Sundquist C, Stromberg S, Edlund K, Ostman A,Nilsson P, Ponten F, Lundeberg J: Expression profiling of microdissected cellpopulations selected from basal cells in normal epidermis and basal cell carcinoma.Br J Dermatol 158: 527-538, 2008
  • Armstrong BK, Kricker A: The epidemiology of UV induced skin cancer. JPhotochem Photobiol B 63: 8-18, 2001
  • Andreasen PA, Kjoller L, Christensen L, Duffy MJ: The urokinase-typeplasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1-22,1997
  • Alam M, Ratner D: Cutaneous squamous-cell carcinoma. N Engl J Med 344: 975-983, 2001